Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX: 4747)

Johnson Chemical Pharmaceutical Works Revenue

Johnson Chemical Pharmaceutical Works had revenue of 150.01M TWD in the quarter ending September 30, 2024, with 1.34% growth. This brings the company's revenue in the last twelve months to 618.33M, up 4.25% year-over-year. In the year 2023, Johnson Chemical Pharmaceutical Works had annual revenue of 606.71M with 22.65% growth.

• Revenue (ttm): 618.33M
• Revenue Growth: +4.25%
• P/S Ratio: 5.14
• Revenue / Employee: 3.64M
• Employees: 167
• Market Cap: 3.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	606.71M	112.04M	22.65%
Dec 31, 2022	494.67M	83.18M	20.21%
Dec 31, 2021	411.49M	-12.52M	-2.95%
Dec 31, 2020	424.02M	-1.32M	-0.31%
Dec 31, 2019	425.34M	13.43M	3.26%